Shell Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Shell Asset Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,553	Closed	-$364K	–	1581
2021 Q1	$364K	Hold	4,553	–	–	0.01%	978
2020 Q4	$359K	Hold	4,553	–	–	0.01%	933
2020 Q3	$200K	Hold	4,553	–	–	﹤0.01%	1047
2020 Q2	$201K	Sell	4,553 -83	-2%	-$3.1K	0.01%	1028
2020 Q1	$166K	Sell	4,636 -71	-2%	-$4.04K	﹤0.01%	1048
2019 Q4	$334K	Sell	4,707 -133	-3%	-$9.65K	0.01%	1026
2019 Q3	$362K	Buy	+4,840	New	+$410K	0.01%	1011

Shell Asset Management's CMD Position: Q2 2021 in Review

Shell Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 4,553 shares — an estimated $364K sold.

Shell Asset Management first reported a position in CMD in Q3 2019 and held it in 7 quarters. The position peaked at $364K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Shell Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Shell Asset Management sold 4,553 Cantel Medical Corporation shares in Q2 2021, an estimated $364K.
Shell Asset Management first reported a position in Cantel Medical Corporation in Q3 2019 and held it in 7 quarters.
Shell Asset Management's Cantel Medical Corporation position peaked at $364K in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Shell Asset Management's 13F filing for Q2 2021, filed 12 Aug 2021.